Health Sciences experts in a variety of fields are part of an international movement to encourage girls and women to enter STEM fields.

Infants and children with poor nutrition and growth are more likely to suffer from a serious respiratory condition that has been linked to comorbidities and early mortality as adults, according to researchers at the University of Arizona Health Sciences. The study, published in The Lancet Respiratory Medicine, is the first to identify early-life risk factors for spirometric restriction in adult life.

The University of Arizona Health Sciences has provided medical care to hundreds of families in need during the pandemic. It’s through free student-run clinics at the College of Medicine – Tucson with a commitment to underserved people, also known as CUP clinics.

John Galgiani, MD, director of the UArizona Valley Fever Center for Excellence, estimated a vaccine would cost $200 million to fully develop. Dr. Galgiani is currently testing a vaccine that will be used in dogs and hopes to deploy to veterinarians by 2023.

For Frank Moreno, MD, professor of psychiatry at the College of Medicine – Tucson, migrants have levels of stress and depression associated with their condition that reflect other social factors, conditions he assures are conducive to developing other types of health problems such as "headaches, ulcers, high blood pressure, problems regulating blood sugar, all chronic diseases are complicated by stress."

Chronic stress among the elderly can make the problem worse, says Roberta Diaz Brinton, PhD, director of the Center for Innovation in Brain Science at the University of Arizona College of Medicine – Tucson. She says that elderly stress caused by everything from loneliness to finances to poor health can make mental decline worse.

A UArizona Health Sciences-led study identified poor childhood nutrition and growth as risk factors for lung disease and weaker health as an adult.

John Galgiani, MD, director of the UArizona Valley Fever Center for Excellence, estimated a vaccine would cost $200 million to fully develop. Dr. Galgiani is currently testing a vaccine that will be used in dogs and hopes to deploy to veterinarians by 2023.

A new center will advance addiction research through collaboration with faculty interested in studying substance use disorders.